학술논문
Efficacy and safety of ‘Second Adjuvant’ therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapy
Document Type
Article
Author
Taylor, A.M.; McKeown, J.; Galea, C.; Woodford, R.; Lo, S.; Long, G.V.; Carlino, M.S.; Menzies, A.M.; Dimitriou, F.; Dummer, R.; Jacques, S.K.; Zimmer, L.; Allayous, C.; Lebbe, C.; Yeoh, H.-L.; Haydon, A.; Ressler, J.M.; Hoeller, C.; Kahler, K.; Hauschild, A.; Festino, L.; Ascierto, P.A.; Schwarze, J.K.; Neyns, B.; Wicky, A.; Michielin, O.; Placzke, J.; Rutkowski, P.; Johnson, D.B.
Source
In: European Journal of Cancer . (European Journal of Cancer, March 2024, 199)
Subject
Language
English
ISSN
18790852
09598049
09598049